The "jewel of the crown" of Minnesota biotechnology wants a prominent place in China's growing biotech economy, too.
The Star Tribune reports that Techne, a Minneapolis biotech and hematology company, is seeing results from its recent expansion into China, despite challenges from knock-offs and counterfeits:
"Less than a year after its Shanghai division began operations in fiscal 2008, it made its first profit and sales grew nearly 22 percent, delivering the largest double-digit sales growth in Techne's biotech division in its last fiscal year," writes Star Tribune reporter Wendy Lee.
Techne, a growing company with 726 employees, creates proteins that are used in medicine and research, including in the development of drugs for cancer and AIDS.